NCT02287467: A trial that was reported late by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported, although it was 105 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02287467 |
|---|---|
| Title | Anti-Influenza Hyperimmune Intravenous Immunoglobulin Clinical Outcome Study (INSIGHT 006: FLU-IVIG) |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Jan. 31, 2015 |
| Completion date | June 7, 2018 |
| Required reporting date | June 7, 2019, midnight |
| Actual reporting date | Sept. 20, 2019 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | 105 |